ChromaDex Corporation (CDXC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
3.79+0.02 (+0.53%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close3.77
Bid3.70 x 600
Ask3.85 x 300
Day's Range3.78 - 3.85
52wk Range1.05 - 6.18
1y Target EstN/A
Market Cap143.48M
P/E Ratio (ttm)-108.29
Avg Vol (3m)438,763
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Thomson Reuters StreetEvents6 days ago

    Edited Transcript of CDXC earnings conference call or presentation 11-Aug-16 8:30pm GMT

    Q2 2016 Chromadex Corp Earnings Call

  • Capital Cube9 days ago

    ETF’s with exposure to Chromadex Corp. : August 19, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Chromadex Corp. Here are 5 ETF’s with the largest exposure to CDXC-US. Comparing the performance and risk of Chromadex Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Chromadex Corp. :CDXC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016
    Capital Cube10 days ago

    Chromadex Corp. :CDXC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016

    Categories: Yahoo Finance Get free summary analysis Chromadex Corp. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Chromadex Corp. – Albany Molecular Research, Inc., Sangamo BioSciences, Inc., Spherix Incorporated and Exelixis, Inc. (AMRI-US, SGMO-US, SPEX-US and EXEL-US) that have also reported for this period. Highlights Summary ... Read more (Read more...)